Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 09, 2019

SELL
$107.15 - $126.84 $1,178 - $1,395
-11 Closed
0 $0
Q4 2018

Jan 24, 2019

BUY
$101.4 - $128.73 $1,115 - $1,416
11 New
11 $1,000
Q3 2018

Oct 09, 2018

SELL
$113.81 - $129.46 $1,251 - $1,424
-11 Closed
0 $0
Q4 2017

Feb 16, 2018

BUY
$118.58 - $151.28 $1,304 - $1,664
11
11 $2,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Mgo One Seven LLC Portfolio

Follow Mgo One Seven LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.